Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Novel biomarkers for sepsis: A narrative review

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. The effect of compression stocking on leg edema and discomfort during a 3-hour flight: A randomized controlled trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. An international perspective on hospitalized patients with viral community-acquired pneumonia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. β-Thalassemia heterozygote state detrimentally affects health expectation

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. The association between pre-operative sepsis and 30-day mortality in hip fracture patients-A cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Kritisk sygdom og måling af vitalparametre hos indlagte patienter

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Sepsis is a prevalent condition among hospitalized patients that carries a high risk of morbidity and mortality. Rapid recognition of sepsis as the cause of deterioration is desirable, so effective treatment can be initiated rapidly. Traditionally, diagnosis was based on presence of two or more positive SIRS criteria due to infection. However, recently published sepsis-3 criteria put more emphasis on organ dysfunction caused by infection in the definition of sepsis. Regardless of this, no gold standard for diagnosis exist, and clinicians still rely on a number of traditional and novel biomarkers to discriminate between patients with and without infection, as the cause of deterioration.

METHOD: Narrative review of current literature.

RESULTS: A number of the most promising biomarkers for diagnoses and prognostication of sepsis are presented.

CONCLUSION: Procalcitonin, presepsin, CD64, suPAR, and sTREM-1 are the best evaluated biomarkers for diagnosis and prognostication of sepsis to date. All have limitations in differentiation between infected and non-infected patients with SIRS, and their future role in diagnosis needs to be evaluated. It is important to test utility, performance, and validity of future biomarkers before implementing them in routine clinical care.

OriginalsprogEngelsk
TidsskriftEuropean Journal of Internal Medicine
Vol/bind45
Sider (fra-til)46-50
ISSN0953-6205
DOI
StatusUdgivet - nov. 2017

ID: 51952143